John Reid

Q: What Schools Are Affiliated With John Reid

John Reid is affiliated with the following schools: University of Oxford, University of Michigan, Royal Postgraduate Medical School, Stanford University, Case Western Reserve University, University of Glasgow, University of California, San Francisco, University of Southampton

John Reid 's AcademicInfluence.com Rankings

John Reid

Medical

#1187

World Rank

#1501

Historical Rank

Pharmacology

#88

World Rank

#114

Historical Rank

medical Degrees

Download Badge

Medical

John Reid 's Degrees

PhD Pharmacology University of California, San Francisco
Doctorate Medicine Stanford University

Why Is John Reid Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John Low Reid is a British clinical pharmacologist. Reid graduated in medicine from the University of Oxford, then completed his training in clinical pharmacology at the Royal Postgraduate Medical School, where he was subsequently a senior lecturer and reader. He also undertook a Medical Research Council travelling fellowship to the United States' National Institutes of Health.

(See a Problem?)

John Reid 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? (1998) (542)
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial (2002) (528)
Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. (1999) (446)
The sympathetic nervous system and the metabolic syndrome. (2007) (369)
1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (1998) (308)
Clinical pharmacology and pharmacokinetics of clonidine (1976) (280)
Pharmacokinetics and concentration‐effect relationships of intravenous and oral clonidine (1977) (267)
Endothelin-1-Induced Reductions in Cerebral Blood Flow: Dose Dependency, Time Course, and Neuropathological Consequences (1993) (250)
Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorticosterone‐Saline Hypertension in Rats (1975) (218)
White-coat hypertension as a cause of cardiovascular dysfunction (1996) (197)
Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus (1997) (183)
1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
Quantitative localization of biogenic amines in the spinal cord (1975) (144)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
CLONIDINE WITHDRAWAL IN HYPERTENSION Changes in Blood-pressure and Plasma and Urinary Noradrenaline (1977) (136)
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. (1975) (133)
Technical report: quantitative assessment of diaphragmatic movement--a reproducible method using ultrasound. (1992) (131)
Interaction between Clonidine and Desipramine in Man (1973) (128)
PRIOR THIAZIDE DIURETIC TREATMENT INCREASES ADRENALINE-INDUCED HYPOKALAEMIA (1983) (127)
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. (1983) (125)
Participation of Central Noradrenergic Neurons in Arterial Baroreceptor Reflexes in the Rabbit: A STUDY WITH INTRACISTERNALLY ADMINISTERED 6‐HYDROXYDOPAMINE (1972) (123)
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. (1982) (121)
The central hypotensive effect of clonidine; Studies in tetraplegie subjcets (1977) (117)
Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. (1995) (116)
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. (1983) (115)
Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat (1990) (112)
Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. (1997) (105)
Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa (1971) (98)
Epinephrine-induced hypokalemia: the role of beta adrenoceptors. (1986) (97)
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
[3H]yohimbine and [3H]idazoxan bind to different sites on rabbit forebrain and kidney membranes. (1988) (95)
Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension. (1997) (93)
Impaired pressor reactivity in cirrhosis: Evidence for a peripheral vascular defect (1991) (92)
Cardiovascular effects of intracerebroventricular d-, l- and dl-propranolol in the conscious rabbit. (1974) (91)
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. (1991) (90)
Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. (1977) (88)
Effect of Area-Based Deprivation on the Severity, Subtype, and Outcome of Ischemic Stroke (2003) (88)
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. (1983) (87)
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. (1984) (83)
Changes in Plasma Norepinephrine, Blood Pressure and Heart Rate During Physical Activity in Hypertensive Man (1979) (83)
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. (1982) (82)
IDIOPATHIC PARKINSONISM TREATED WITH BROMOCREPTINE (1975) (80)
Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. (1985) (80)
Effect of Age on the Responsiveness of Vascular α‐Adrenoceptors in Man (1982) (79)
Noradrenaline release and clearance in relation to age and blood pressure in man (1982) (79)
Pharmacokinetics of calcium antagonists. (1988) (78)
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit (1973) (74)
The metabolism and kinetics of doxazosin in man, mouse, rat and dog. (1986) (73)
Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis. (1999) (70)
Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man. (1985) (69)
Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man. (1981) (69)
Effects of nitric oxide and superoxide on relaxation in human artery and vein. (1997) (68)
The effect of age on the responses of human isolated arteries to noradrenaline. (1982) (67)
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. (1984) (67)
Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. (2000) (67)
Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial (2006) (66)
The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents. (1981) (65)
The effect of captopril on the reflex control heart rate: possible mechanisms. (1985) (62)
Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. (1998) (62)
Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. (1986) (62)
Interindividual variation in kinetics of infused epinephrine (1979) (61)
Measuring therapy adherence in Parkinson’s disease: a comparison of methods (2006) (61)
Peptides and central neural regulation of the circulation. (1987) (60)
Susceptibility to cerebral infarction in the stroke-prone spontaneously hypertensive rat is inherited as a dominant trait. (1998) (60)
A species difference in the presystemic metabolism of carbazeran in dog and man. (1984) (59)
Analysis of the pressor dose response (1982) (58)
Immediate cardiovascular responses to oral prazosin—Effects of concurrent β‐blockers (1981) (57)
Biochemical and histochemical studies of biogenic amines in spinal cord trauma (1976) (56)
Evidence for postjunctional vascular alpha 2-adrenoceptors in peripheral vascular regulation in man. (1983) (56)
Prazosin disposition in young and elderly subjects. (1981) (54)
Nifedipine: Individual Responses and Concentration‐Effect Relationships (1988) (54)
Alpha-adrenergic receptors and blood pressure control. (1986) (54)
Moxonidine: A Second-generation Central Antihypertensive Agent (1993) (54)
Acute Effects of Phenoxybenzamine on α‐Adrenoceptor Responses In Vivo and In Vitro: Relation of In Vivo Pressor Responses to the Number of Specific Adrenoceptor Binding Sites (1983) (53)
Verapamil pharmacokinetics and apparent hepatic and renal blood flow. (1985) (52)
Plasma noradrenaline concentrations in experimental renovascular hypertension in the rat. (1977) (51)
Clinical pharmacological aspects of calcium antagonists and their therapeutic role in hypertension. (1985) (51)
Changes in noradrenaline concentration in brain stem and hypothalamic nuclei during the development of renovascular hypertension (1977) (51)
The role of adrenal medullary catecholamines in potassium homoeostasis. (1984) (51)
Participation of Adrenergic and Noradrenergic Neurones in Central Connections of Arterial Baroreceptor Reflexes in the Rat (1979) (50)
Effects of a Xanthine Oxidase/Hypoxanthine Free Radical and Reactive Oxygen Species Generating System on Endothelial Function in New Zealand White Rabbit Aortic Rings (1993) (50)
The cardiovascular effects of bromocriptine in Parkinsonism. (1976) (49)
The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke (2004) (49)
Influence of age on the pharmacokinetics and pharmacodynamics of perindopril (1988) (49)
Opiate Analogs, Substance P, and Baroreceptor Reflexes in the Rabbit (1981) (48)
Transamination is a Major Pathway of L-Dopa Metabolism following Peripheral Decarboxylase Inhibition (1974) (47)
Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release. (1994) (47)
Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patients (1980) (47)
Plasma noradrenaline, age and blood pressure: a population study. (1978) (47)
Significance of plasma dopamine beta-hydroxylase activity as an index of sympathetic neuronal function. (1974) (46)
Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. (1984) (46)
Clinical pharmacological studies with doxazosin. (1986) (46)
Regional impairment of cerebral oxidative metabolism in Parkinson's disease. (1979) (46)
Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment (1987) (45)
Lateral diffusion and fatty acid composition in vascular smooth muscle membrane from stroke-prone spontaneously hypertensive rats. (1993) (45)
SELECTIVE VENOUS SAMPLING IN THE DIAGNOSIS AND LOCALIZATION OF PHAEOCHROMOCYTOMA (1979) (45)
Parkinsonism treated with 3‐0‐methyldopa (1973) (44)
Sedative and cardiovascular effects of clonidine and nitrazepam (1980) (44)
Combination of Nifedipine and Doxazosin in Essential Hypertension (1992) (44)
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial (2005) (44)
Catecholamine synthesizing enzymes in brain stem and hypothalamus during the development of renovascular hypertension (1979) (44)
Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. (1986) (43)
Labetalol disposition and concentration-effect relationships during pregnancy. (1983) (42)
From kinetics to dynamics: are there differences between ACE inhibitors? (1997) (42)
Clinical Pharmacokinetics of Prazosin — 1985 (1985) (42)
Dose‐Ranging Study of the Angiotensin Type I Receptor Antagonist Losartan (DuP753/MK954), in Salt‐Deplete Normal Man (1993) (42)
Captopril versus perindopril: a double blind study in essential hypertension. (1989) (41)
Apparent resistance to hypotensive effect of clonidine. (1977) (41)
Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. (1996) (41)
Pharmacological characterisation of endothelium-dependent relaxation in human radial artery: comparison with internal thoracic artery. (1999) (41)
1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjects (1984) (40)
Imidazole binding sites in rabbit kidney and forebrain membranes. (1991) (40)
Fixed dose combination therapy in the treatment of hypertension (2002) (40)
Choice of control groups in the appraisal of sympathetic nervous activity in essential hypertension. (1979) (40)
Central hypotensive effect of propranolol in the rabbit. (1973) (39)
Cardiovascular and autonomic reflexes in haemodialysis patients. (1981) (39)
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension. (1996) (38)
Perindopril. A review of its pharmacokinetics and clinical pharmacology. (1990) (37)
Endogenous opioids and baroreflex control in humans. (1983) (37)
Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs. (1991) (37)
The effects of ganglionic blockade, reserpine and vinblastine on plasma catecholamines and dopamine-beta-hydroxylase in the rat. (1975) (37)
Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. (1995) (37)
The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. (1986) (37)
Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension (1977) (36)
The importance of central adrenergic neurones in renal hypertension in rabbits (1974) (36)
DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension. (2000) (36)
The alpha adrenoceptor antagonist properties of idazoxan in normal subjects (1984) (35)
Sequential changes in plasma noradrenaline during bicycle exercise. (1980) (35)
Rilmenidine: a clinical overview. (2000) (35)
Effects of ACE inhibitors on oxidation of human low density lipoprotein. (1994) (35)
Antihypertensive effects of clonidine in tetraplegic subjects devoid of central sympathetic control. (1979) (35)
A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man. (1987) (35)
Sedative and cardiovascular effects of clonidine and nitrazepam. (1981) (35)
Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man. (1987) (34)
Angiotensin receptor antagonists as a treatment for hypertension. (1994) (34)
Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. (1982) (34)
Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans. (1982) (34)
Haemodynamic and Renal Responses to Oral Losartan Potassium During Salt Depletion or Salt Repletion in Normal Human Volunteers (1995) (34)
The symptoms of patients treated for Parkinson's disease. (1985) (33)
Coordinating and standardizing long-term care: evaluation of the west of Scotland shared-care scheme for hypertension. (1994) (33)
Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (33)
The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension. (1986) (33)
Calcium antagonists and hormone release: effect of nifedipine on luteinizing hormone-releasing hormone and thyrotropin-releasing hormone-induced pituitary hormone release. (1983) (33)
Desmethylimipramine and the hypotensive action of clonidine in the rabbit. (1972) (32)
A comparison of the disposition of single oral doses of amlodipine in young and elderly subjects. (1988) (32)
The cardiovascular actions of clonidine and neuropeptide‐Y in the ventrolateral medulla of the rat (1989) (32)
Effects of endothelin upon blood pressure in normotensive rabbits and in perinephritis hypertension (1992) (31)
The biochemical diagnosis, localization and follow up of phaeochromocytoma: the role of plasma and urinary catecholamine measurements. (1980) (31)
HOMOVANILLIC ACID AND 3‐METHOXY‐4‐ HYDROXYPHENYLETHYLENEGLYCOL PRODUCTION BY THE MONKEY SPINAL CORD (1976) (31)
The effects of perindopril on vascular smooth muscle polyploidy in stroke‐prone spontaneously hypertensive rats (1995) (30)
Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. (1985) (30)
Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose. (1993) (30)
Endothelin, cerebral ischaemia and infarction. (1995) (30)
A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects. (1992) (30)
The experiences of an acute stroke unit--implications for multicentre acute stroke trials. (1993) (30)
COMPARISON OF LEVODOPA WITH CARBIDOPA OR BENSERAZIDE IN PARKINSONISM (1976) (30)
Identification and characterisation of beta-adrenoceptors in guinea-pig skeletal muscle. (1987) (30)
The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow. (1985) (29)
Catecholamine neurotransmitters and synthetic enzymes in the spinal cord of the rat. (1975) (29)
Concentration-effect analysis of antihypertensive drug responses. (1990) (29)
Update on rilmenidine: clinical benefits. (2001) (29)
Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man. (1986) (29)
Effect of naloxone on the actions of captopril (1985) (28)
Angiotensin converting enzyme inhibitors in the elderly. (1987) (28)
Differences between calcium antagonists: duration of action and trough to peak ratio (1993) (28)
Inhibition by omeprazole of adrenocortical response to ACTH: clinical studies and experiments on bovine adrenal cortex in vitro. (1986) (28)
Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men. (1996) (28)
The pharmacokinetics of doxazosin in elderly normotensives. (1986) (28)
Plasma noradrenaline and renovascular hypertension in the rat. (1976) (28)
The effects of spinal cord transection and intracisternal 6‐hydroxydopamine on phenylethanolamine‐N‐methyl transferase (PNMT) activity in rat brain stem and spinal cord (1976) (28)
Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension. (1983) (27)
Atenolol disposition in young and elderly subjects. (1982) (27)
Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. (1984) (27)
Plasma noradrenaline concentrations at different vascular sites during rest and isometric and dynamic exercise. (1979) (27)
The role of α‐ and β‐adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat (1990) (26)
Oxidized-LDL induced changes in membrane physico-chemical properties and [Ca2+]i of bovine aortic endothelial cells. Influence of vitamin E. (1995) (25)
Pharmacokinetic and pharmacodynamic studies with two α‐adrenoceptor antagonists, doxazosin and prazosin in the rabbit (1985) (25)
The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension. (1993) (25)
Double‐Blind Comparison of the Cardioselective &bgr;‐Blockers Bisoprolol and Atenolol in Hypertension: The Bisoprolol International Multicenter Study (BIMS) (1985) (25)
Omeprazole, a gastric ‘proton pump inhibitor’: Lack of effect on renal handling of electrolytes and urinary acidification (2004) (25)
Cardiovascular reflexes in Parkinsonism. (1971) (25)
The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection. (1981) (25)
Review: Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension? (2005) (25)
Vasorelaxant properties of isolated human radial arteries: comparison with internal mammary arteries. (2002) (24)
Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril. (1985) (24)
Hypercholesterolaemia in treated hypertensives: a controlled trial of intensive dietary advice. (1989) (24)
Role of central dopaminergic mechanisms in piribedil and clonidine induced hypothermia in the rat (1975) (24)
A postsynaptic location of alpha 2 adrenoceptors in vascular smooth muscle: in vivo studies in the conscious rabbit. (1982) (24)
THE EFFECTS OF INTRAVENTRICULAR 6‐HYDROXYDOPAMINE ON BODY TEMPERATURE AND ARTERIAL BLOOD PRESSURE IN CATS AND RABBITS (1974) (24)
Maternal and Fetal Platelet Responses and Adrenoceptor Binding Characteristics (1985) (24)
THE ROLE OF PRESYNAPTIC α‐ADRENOCEPTORS IN THE REGULATION OF BLOOD PRESSURE IN THE CONSCIOUS RABBIT (1982) (24)
Changes in brain α-adrenoceptors with increasing age in rabbits (1984) (23)
Importance of central catecholaminergic neurones in the development and maintenance of renal hypertension. (1973) (23)
RX781094, a new potent alpha 2 adrenoceptor antagonist. In vivo and in vitro studies in the rabbit. (1983) (23)
Application of Pharmacokinetic-Pharmacodynamic Modelling for the Comparison of Quinazoline α-Adrenoceptor Agonists in Normotensive Volunteers (1985) (23)
Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Effects of simvastatin treatment. (1995) (23)
Does labetalol increase excretion of urinary catecholamines? (1978) (23)
Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors? (1986) (23)
Atenolol in the treatment of essential hypertension during pregnancy. (1982) (23)
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase. (1972) (23)
CENTRAL AND PERIPHERAL NORADRENALINE IN THE TWO KIDNEY MODEL OF RENOVASCULAR HYPERTENSION IN THE RAT (1977) (23)
Recovery in vivo and in vitro of alpha-adrenoceptor responses and radioligand binding after phenoxybenzamine. (1982) (22)
A comparison of the management of hypertensive patients by nurse practitioners compared with conventional hospital care. (1990) (22)
Cardiovascular significance of neuropeptide Y in the caudal ventrolateral medulla of the rat (1988) (22)
Clinical Pharmacology of Drugs Acting on Imidazoline and Adrenergic Receptors (1995) (22)
Pharmacokinetics of an ACE inhibitor, S-9780, in man: Evidence of tissue binding (1989) (22)
Hypertension 1988: present challenges and future strategies. (1988) (22)
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo (2004) (22)
Central Alpha2 Receptors and the Regulation of Blood Pressure in Humans (1985) (22)
The renin-angiotensin system and the heart: a historical review (1996) (22)
The central hypotensive action of clonidine and propranolol in animals and man. (1977) (22)
An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. (2005) (22)
Clinical Studies with the Potassium Channel Activator Cromakalim in Normotensive and Hypertensive Subjects (1990) (21)
Reduction in local cerebral blood flow induced by endothelin-1 applied topically to the middle cerebral artery in the rat. (1991) (21)
Radial artery hypertrophy occurs in coronary atherosclerosis and is independent of blood pressure. (2001) (21)
The combination of prazosin and verapamil in the treatment of essential hypertension (1988) (21)
HYPOTHERMIC ACTION OF BROMOCRIPTINE (1975) (21)
Alpha adrenoceptors and autonomic mechanisms in perinephritis hypertension in the rabbit. (1983) (21)
Responses to an Orally Active Renin Inhibitor, Remikiren (Ro 42–5892), After Controlled Salt Depletion in Humans (1995) (21)
Down-regulation of imidazoline sites in rabbit kidney. (1993) (21)
Brain and autonomic mechanisms in hypertension. (1994) (20)
The clinical pharmacology of clonidine: relationship between plasma concentration and pharmacological effect in animals and man. (1980) (20)
DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? (1983) (20)
Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit (1988) (20)
Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II. (1995) (20)
Demethylation of 3-O-methyldopa in the rat (1971) (20)
Enalapril and autonomic reflexes and exercise performance. (1983) (19)
Effect of Calcium Channel Blockers on Adrenergic and Nonadrenergic Vascular Responses in Man (1985) (19)
Role of angiotensin in the extravascular system. (1993) (19)
The action of L(-)-dopa on baroreflexes in Parkinsonism. (1972) (19)
Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man. (1993) (18)
A study of the acute pharmacodynamic interaction of ramipril and felodipine in normotensive subjects. (1991) (18)
Vascular and Aldosterone Responses to Angiotensin II in Normal Humans: Effects of Nicardipine (1985) (18)
Regulation of beta-adrenoceptors in the guinea pig left ventricle and skeletal muscle following chronic agonist treatment. (1990) (18)
Plasma noradrenaline and hypertension. (1977) (18)
COMPARISON OF THE ACTIONS OF CENTRALLY AND PERIPHERALLY ADMINISTERED CLONIDINE AND GUANFACINE IN THE RABBIT: INVESTIGATION OF THE DIFFERENCES (1982) (18)
Catecholamines and Blood Pressure Regulation: The Role of &agr;‐Adrenoceptors (1980) (18)
Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension. (1982) (18)
Guanfacine: effects of long-term treatment and withdrawal. (1980) (17)
IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
Alpha-adrenoceptor changes after oestrogen treatment in platelets and other tissues in female rabbits. (1985) (17)
Opioid peptides and central control of blood pressure. (1984) (17)
Concentration effect modelling with converting enzyme inhibitors in man. (1983) (17)
Differences in the regulation of [3H]idazoxan and [3H]yohimbine binding sites in the rabbit. (1990) (17)
Vasorelaxant Properties of Isolated Human Internal Mammary Arteries and Saphenous Veins: Comparative Effects of Milrinone and Sodium Nitroprusside (1993) (17)
Membrane microviscosity does not correlate with blood pressure: a cosegregation study (1993) (17)
The Effects of Chronic Administration of Adrenaline on the Function and Number of Adrenoceptors in the Rabbit (1988) (17)
The effect of central serotonin depletion on DOCA-saline hypertension in the rat. (1974) (17)
Differences in inositol phosphate production in blood vessels of normotensive and spontaneously hypertensive rats (1991) (17)
Adrenaline, Hypokalaemia and Cardiac Arrhythmias: Effects of Beta Adrenoceptor Antagonists (1982) (17)
A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist. (1992) (16)
Relationship between plasma prazosin concentrations and α‐antagonism in humans: Comparison of conventional and rate‐controlled (Oros) formulations (1988) (16)
Increased Levels of Superoxide in Brains from Old Female Rats (2004) (16)
Mechanism of cardiovascular effects of clonidine in conscious and anesthetized rabbits. (1977) (16)
The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat. (1990) (16)
The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol. (1991) (16)
Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog. (1992) (16)
Free and total 3-methoxy-4-hydroxyphenylethylene glycol in human cerebrospinal fluid: relationship to blood pressure in hypertensives and patients with neuropsychiatric disease. (1977) (16)
Clinical Pharmacological Studies on the Interaction Between α‐Adrenoceptors and Calcium Antagonists (1985) (16)
The E.L.S.A. Trial: Protocol of a Randomized Trial to Explore the Differential Effect of Antihypertensive Drugs on Atherosclerosis in Hypertension (1994) (16)
CENTRAL α2‐ADRENOCEPTORS AND BLOOD PRESSURE REGULATION IN MAN: STUDIES WITH GUANFACINE (BS100‐141) AND AZEPEXOLE (BHT 933) (1983) (16)
Central and Peripheral α-Adrenoceptor Number and Responsiveness After Sinoaortic Denervation in the Rabbit (1982) (16)
Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker. (1983) (16)
The clinical pharmacology of a herbal asthma cigarette. (1980) (16)
Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure. (1993) (16)
Analysis of biogenic amines and their metabolites in biological tissues and fluids by gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS). (1990) (16)
Endothelin-1-induced hypertension: a consequence of medullary ischemia? (1991) (16)
Effects of lead exposure on rat brain catecholaminergic neurochemistry. (1988) (16)
Nicardipine combined with enalapril in patients with essential hypertension (1986) (16)
Preliminary experience with a hospital blood pressure follow up clinic with nurse practitioner assessment and microprocessor based data retrieval. (1984) (15)
Effects of Intravenous S‐9780, an Angiotensin‐Converting Enzyme Inhibitor, in Normotensive Subjects (1987) (15)
Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension. (2010) (15)
Plasma converting enzyme activity (C.E.A.): an index of plasma levels of captopril? (1980) (15)
A comparison of α2-adrenoceptor regulation in brain and platelets (1985) (15)
Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (15)
Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril (1992) (15)
Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. (1994) (15)
Predictability of antihypertensive responsiveness and α‐adrenoceptor antagonism during prazosin treatment (1989) (15)
Comparison of the Oral Angiotensin II Receptor Antagonist UP 269–6 or Enalapril 20 mg on Blood Pressure and Neurohormonal Effects in Salt‐Deplete Man (1995) (14)
Attempts to uncover subtypes of alpha-adrenoceptors and associated mechanisms by using sequential administration of blocking drugs. (1985) (14)
Acute and chronic regulation of alpha 2-adrenoceptor number and function in man. (1985) (14)
Central noradrenergic mechanisms and the cardiovascular effects of intracerebroventricular (+)- and (−)-propranolol in the conscious rabbit (1975) (14)
Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension. (1982) (14)
23 ELSA, European Lacidipine Study on Atherosclerosis (1993) (14)
Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa. (1978) (14)
The influence of naloxone on the circulatory effects of captopril. (1984) (14)
Acute and Chronic Beta‐Receptor Blockade with Propranolol and the Cardiovascular Responses to Intravenous Sodium Nitroprusside in the Conscious Rabbit (1979) (14)
Comparative Effects of Rilmenidine and Atenolol on Tests of Autonomic Function and Mental and Dynamic Exercise in Patients with Essential Hypertension (1995) (14)
The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis. (1989) (14)
Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. (1993) (14)
The role of skeletal muscle beta-adrenoreceptors in the regulation of plasma potassium. (1987) (14)
The effect of SQ 14225 on baroreceptor reflex sensitivity in conscious normotensive rabbits [proceedings]. (1978) (14)
Cardiac and Lymphocyte β‐Adrenoceptors in Perinephritis Hypertension in the Rabbit (1986) (14)
The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension. (1989) (13)
The effect of antacids and metoclopramide on omeprazole absorption and disposition. (1988) (13)
Alpha-adrenoceptor number and function in platelets from treated and untreated patients with essential hypertension and age- and sex-matched controls. (1985) (13)
Peripheral α1- and α2-Adrenoreceptor Mechanisms in Blood Pressure Control (1983) (13)
Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice? (1990) (13)
The effect of opiates on arterial baroreceptor reflex function in the rabbit (1982) (13)
Effects of Chronic Beta‐Adrenoceptor Antagonism on Plasma Catecholamines and Blood Pressure in Hypertension (1980) (13)
Regulation of β1- and ß2-adrenoceptors following chronic treatment with ß-adrenoceptor antagonists (1989) (13)
Autoradiographic evaluation of forskolin and D1 dopamine receptor binding in a rat model of focal cerebral ischaemia (1992) (13)
Pharmacodynamic studies with a specific alpha 2-adrenoceptor agonist (BHT-933) in man. (1982) (13)
Mechanism of beta-blockade hypotension. (1973) (13)
Pharmacokinetics and pharmacodynamics of trimazosin in man. (1983) (13)
Clinical pharmacology of selective alpha blockers. Hemodynamics and effects on lipid levels. (1987) (13)
Prolonged converting enzyme inhibition following captopril in patients with renal insuffficiency. (1982) (13)
The influence of cilazapril on indices of autonomic function in normotensives and hypertensives. (1989) (13)
Influence of lead exposure on catecholamine metabolism in discrete rat brain nuclei. (1988) (12)
Action of L‐α‐methyldopahydrazine on the blood pressure of patients receiving levodopa (1972) (12)
Angiotensin converting enzyme inhibitors in the elderly. (1989) (12)
Comparison of fentanyl and halothane supplementation to general anaesthesia on the stress response to upper abdominal surgery. (1984) (12)
Risk factor modification in hypertension--success and failure. (1987) (12)
Analysis of biogenic amines in plasma of hypertensive patients and a control group (1993) (12)
Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors (1977) (12)
The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects. (1983) (12)
The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension. (1995) (12)
Effects of nicardipine on aldosterone release and pressor mechanisms. (1985) (12)
Endothelin stimulates phosphatidylinositol hydrolysis in rat vascular smooth muscles. (1989) (11)
Left ventricular hypertrophy and arterial blood pressure in experimental models of hypertension. (1997) (11)
First-line and combination treatment for hypertension. (1989) (11)
In vivo and in vitro studies of the site of inhibitory action of omeprazole on adrenocortical steroidogenesis (2004) (11)
Plasma noradrenaline concentration in essential hypertension during long-term beta-adrenoceptor blockade with oxprenolol. (1980) (11)
Plasma concentration of α-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester (1975) (11)
Dose-plasma concentration--effect relationship of felodipine in essential hypertension: a review. (1990) (11)
Captopril and baroreceptor reflex responses to pressor and depressor stimuli in the rabbit. (1981) (11)
Acute thermoregulatory and cardiovascular effects of 6-hydroxydopamine administered centrally in rabbits and cats. (1972) (11)
Pharmacokinetic and pharmacodynamic aspects of the choice of components of combination therapy. (1995) (11)
Central and peripheral catecholamine mechanisms in circulatory control. (1976) (11)
An Investigation into the Effects of Omeprazole on Renal Tubular Function and Endocrine Function in Man (1986) (11)
Lisinopril and nifedipine: no acute interaction in normotensives. (1988) (11)
Chronic exposure of bovine aortic endothelial cells to native and oxidized LDL modifies phosphatidylinositol metabolism. (1994) (10)
Metabolic effects of lacidipine: a placebo-controlled study using the euglycaemic hyperinsulinaemic clamp. (1993) (10)
Effect of haemodialysis on the control of the circulation in patients with chronic renal failure. (1985) (10)
Effects of Captopril, an Angiotensin‐Converting Enzyme Inhibitor, in Normotensive Sodium‐Replete Volunteers (1982) (10)
Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes (2004) (10)
Plaque Hypertension Lipid‐Lowering Italian Study (PHYLLIS): a protocol for non‐invasive evaluation of carotid atherosclerosis in hypercholesterolaemic hypertensive subjects (1993) (10)
New therapeutic agents for hypertension. (2003) (10)
Does potassium channel opening contribute to endothelium-dependent relaxation in human internal thoracic artery? (1999) (10)
The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man (2004) (10)
Studies with low dose intravenous diacid ACE inhibitor (perindoprilat) infusions in normotensive male volunteers. (1992) (10)
Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide. (1978) (10)
Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans. (1986) (10)
Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers. (1994) (10)
Effects of short-term exposure to noradrenaline and adrenaline on adrenoceptor responses. (1989) (9)
Haemodynamic, metabolic, and lymphocyte beta2-adrenoceptor changes following chronic beta-adrenoceptor antagonism (2004) (9)
Do rat tissues possess 5‐hydroxytryptamine‐oxidizing activity distinct from monoamine oxidase A? (1979) (9)
DOXAZOSIN,AN a-ADRENOCEPTORANTAGONIST: PHARMACOKINETICSAND CONCENTRATION- EFFECTRELATIONSHIPSINMAN (1983) (9)
Quantitative localization of tyrosine hydroxylase, dopamine-β-hydroxylase, phenolethanolamine-N-methyl transferase, and glutamic acid decar☐ylase in spinal cord (1976) (9)
Proceedings: The sympathetic nervous system and renovascular hypertension in the rat. (1976) (9)
The effects of omeprazole on endocrine function in man (2004) (9)
Studies on alpha 2-adrenoceptors in rabbits with perinephritis hypertension. (1986) (9)
Pertussis toxin sensitive endothelin-1 coupling to inositol phosphate formation via a GTP-binding protein: comparison in SHR and WKY cultured aortic smooth muscle cells. (1995) (9)
Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure (2004) (9)
Signal transduction mechanisms of the vasoconstriction in hypertension. (1994) (9)
Ketanserin concentration-effect relationships in individual hypertensive patients. (1988) (9)
The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients (2004) (9)
The effects of phenoxybenzamine on specific binding and function of central α-adrenoceptors in the rabbit (1985) (9)
THE CLINICAL PHARMACOLOGY OF ACE INHIBITORS: EVIDENCE FOR CLINICALLY RELEVANT DIFFERENCES? (1992) (9)
Noradrenaline concentration in hypothalamic and brain stem nuclei of renovascular hypertensive rats [proceedings]. (1977) (9)
Letter: Clonidine overdose. (1975) (9)
Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation. (1984) (9)
Do centrally-acting antihypertensive drugs act at non-adrenergic as well as alpha-2 adrenoceptor sites? (1992) (9)
Efficacy and Tolerability of Long-Term Rilmenidine Treatment in Hypertensive Diabetic Patients (2004) (8)
A comparative study of automated blood pressure recorders. (1980) (8)
Binding studies of platelet alpha 2- and lymphocyte beta 2-adrenoceptors in patients with cirrhosis. (1990) (8)
Sodium-lithium countertransport, sodium-hydrogen exchange and membrane microviscosity in patients with hyperlipidaemia. (1997) (8)
Lecture Notes: Clinical Pharmacology and Therapeutics (2011) (8)
Animal evaluation of a new pericardial bioprosthetic heart valve. (1988) (8)
Effects of neuropeptide Y on forskolin, alpha2- and beta-adrenoceptor-regulated cAMP levels in the rat brain slice (1991) (8)
Increased vascular sensitivity to noradrenaline in hypertensive renal transplant recipients. (1983) (8)
Exercise and platelet intracellular free calcium concentration. (1988) (8)
Desensitization and down-regulation of brain alpha 2-adrenoceptors by centrally acting antihypertensive drugs. (1990) (8)
Plasma catecholamines in pregnancy induced hypertension. (1986) (8)
Plasma catecholamines and modes of delivery: the relation between catecholamine levels and in‐vitro platelet aggregation and adrenoreceptor radioligand binding characteristics. (1985) (8)
Lecture Notes on Clinical Pharmacology (1982) (8)
The Relationship Between the Hypokalaemic Response to Adrenaline, β‐Adrenoceptors, and Na+-K+ Pumps in Skeletal and Cardiac Muscle Membranes in the Rabbit (1990) (8)
Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metabolite (1983) (8)
Clinical pharmacology and therapeutics--past, present and future. (2003) (7)
Catecholamine turnover in essential hypertension. (1980) (7)
Inositol phosphate formation in arterial smooth muscle from rabbits with perinephritis hypertension. (1990) (7)
Trimazosin in normotensive subjects (1984) (7)
The effect of noradrenaline infusion on blood pressure and plasma noradrenaline following clonidine administration in man [proceedings]. (1977) (7)
Doppler Ultrasound Detection of Cerebral Emboli in Patients with Mechanical Heart Valves: Correlation with Neurological Deficit (1992) (7)
AN ANALYSIS OF THE PRESSOR RESPONSES TO PUTATIVE α1, AND α2-ADRENORECEPTOR AGONISTS GIVEN INTRAVENOUSLY TO CONSCIOUS RABBITS (1984) (7)
The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording. (1991) (7)
Adrenergic components of hypertension after renal transplantation. (1981) (7)
Effects of Prolonged and Brief Infusions of Noradrenaline on Arterial Pressure and on the Plasma Concentrations of Active Renin, Angiotensin II, Aldosterone and Potassium (1983) (7)
Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs. (1983) (7)
Urinary conjugates of 4-hydroxy-3-methoxyphenylethylene glycol do not provide an index of brain amine turnover in man. (1980) (7)
Catecholamines and Blood Pressure (1989) (7)
PROGRESS – perindopril protection against recurrent stroke study: status in July 1996 (1996) (7)
The effects of sexual maturation on α-adrenoceptors in female rabbits (1985) (7)
Efficacy and tolerability of long-term rilmenidine treatment in hypertensive diabetic patients. A retrospective analysis of a general practice study. (2004) (7)
Idazoxan and brain α 2-adrenoceptors in the rabbit (1988) (7)
Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist. (1983) (7)
Volume expansion and vasodilators in the treatment of idiopathic postural hypotension. (1980) (7)
Commentary on Workshop on α-Adrenoceptors (1985) (7)
Percutaneous transluminal renal angioplasty in the management of hypertension and renal failure in patients with renal artery stenosis. (1993) (7)
Comparison of endothelin-1 and noradrenaline stimulated inositol phosphate formation in cultured aortic smooth muscle cells from spontaneously hypertensive and Wistar Kyoto rats. (1993) (7)
Trimazosin: Relationships Between Hypotensive Effect, Vascular Responsiveness, and Drug and Metabolite Concentrations (1985) (7)
Plasma nifedipine levels and fall in blood pressure in a 53 year old woman. (1983) (7)
Specific alterations in cardiovascular function and in glucose utilisation within lower brainstem nuclei following intracisternal neuropeptide Y in the conscious rat (1990) (7)
Withdrawal of guanfacine after long-term treatment in essential hypertension (2004) (6)
Regulation of β-adrenoceptors by catecholamines in the rabbit skeletal muscle (1988) (6)
Endothelium dependent and independent relaxation of aortic rings from Watanabe heritable hyperlipidemic rabbits after exposure to free radical generating system. (1998) (6)
RX781094, a new potent α2 adrenoceptor antagonist (1983) (6)
Policies for managing hypertensive patients: a survey of the opinions of British specialists. (1990) (6)
Effects of the calcium antagonist lacidipine on insulin sensitivity in essential hypertension. A placebo-controlled study. (1994) (6)
Effects of manipulation of dietary cholesterol on the function of the thoracic aorta from New Zealand white rabbits. (1996) (6)
Non-invasive study of the metabolism-to-blood flow relationship in Parkinson's disease. (1977) (6)
Effect of age on vascular a-adrenoceptor responsiveness in man (1982) (6)
The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man (2004) (6)
Changes in alpha-adrenoceptors during long-term treatment of rabbits with prazosin. (1981) (6)
Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man. (1990) (6)
Neurohormonal and Blood Pressure Responses to Low-Dose Infusion of an Orally Active Renin Inhibitor, Ro 42-5892, in Salt-Replete Men (1992) (6)
Demethylation of 3-O-methyldopa. (1971) (6)
Pharmacodynamic Studies in Normal Volunteers with MDL‐899, a New Arteriolar Vasodilator (1983) (6)
THE CONTRIBUTION OF CENTRAL AND PERIPHERAL ADRENOCEPTORS TO THE ACTIONS OF CLONIDINE AND ALPHA METHYLDOPA IN MAN (1980) (6)
Changes in brain alpha-adrenoceptors with increasing age in rabbits. (1984) (6)
Labetalol and the Management of Hypertension (1981) (6)
Placebo‐Controlled Trial of Doxazosin in Management of Patients with Hypertension and Hypercholesterolaemia (1992) (6)
The Effect of Clonidine on Biochemical Indices of Sympathetic Function in Normotensive Subjects (1976) (6)
Phosphoinositide metabolism and aging in aorta from SHR and WKY rats: effects of endothelin-1 and noradrenaline. (1994) (6)
The relationship between serum enalaprilat concentration and the hypotensive effect in man. (1987) (6)
Neuropeptide Y-induced inositol phospholipid hydrolysis in blood vessels from normotensive and spontaneously hypertensive rats. (1993) (6)
A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril. (1993) (6)
Effect of chronic pretreatment of guinea-pigs with beta-adrenoceptor agonists on the Na+,K(+)-pump in skeletal muscle. (1990) (6)
EFFECTS OF AGE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CARDIOVASCULAR DRUGS: APPLICATION OF CONCENTRATION‐EFFECT MODELING. 3. TRIMAZOSIN (1995) (6)
Recovery of alpha-adrenoreceptor mediated responses and binding site number after intravenous benextramine in the rabbit. (1985) (5)
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man. (1980) (5)
The recovery of α-adrenoceptor function and binding sites after phenoxybenzamine (2004) (5)
Strategies for dynamic assessment of sympathetic activity from plasma catecholamine measurements (1984) (5)
Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects. (1982) (5)
Present aspects and future developments with ACE inhibitors. (1989) (5)
Antiparkinsonian Drugs: Pharmacological and Therapeutic Aspects (2012) (5)
Central and peripheral mechanisms in the maintenance of experimental hypertension in the rabbit. (1973) (5)
Prolonged infusion of norepinephrine in the conscious dog: effects on blood pressure, heart rate, renin, angiotensin II, and aldosterone. (1982) (5)
Selective α2-adrenoceptor blockade does not enhance glucose-evoked insulin release (1990) (5)
Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties. (1984) (5)
High-dose oral methotrexate. (1981) (5)
BLOOD PRESSURE AND CORRELATIONS (1985) (5)
The pharmacokinetics of bucindolol and its major metabolite in essential hypertension. (1985) (5)
Plasma nifedipin levels and fall in blood pressure in a 53 year old woman (2004) (5)
Factors determining the response to calcium antagonists in hypertension. (1988) (5)
The effects of intracisternal 6-hydroxydopamine on the development of neurogenic hypertension in the rabbit. (1971) (5)
The 'third drug' trial: a comparative study of anti-hypertensive agents added to treatment when blood pressure is uncontrolled by a beta-blocker plus thiazide diuretic. (1983) (5)
Levodopa and pressor amine sensitivity in parkinsonism (1972) (5)
Pharmacokinetics of perindopril: therapeutic consequences. (1989) (5)
Hypertension and the brain. (1994) (5)
Pharmacokinetic and pharmacological studies with clonidine in normal subjects. (1976) (5)
Low-dose verapamil in middle-aged and elderly patients with angina pectoris: No evidence of increased susceptibility to the cardiac effects (1992) (5)
Long-term amitriptyline treatment alters the affinity state of alpha 2 adrenoceptors in rabbit hindbrain. (1986) (5)
Changes in rabbit platelet α and β adrenoceptor number and platelet aggregation (1986) (5)
Determinants of the blood pressure response to the first dose of ACE inhibitor in mild to moderate congestive heart failure. (1998) (5)
Risks of socioeconomic deprivation on mortality in hypertensive patients (2009) (5)
2790 – S 100-141 A CENTRALLY ACTING ANTIHYPERTENSIVE DRUG: EFFECTS ON BLOOD PRESSURE AND PLASMA AND URINARY NORADRENALINE IN ESSENTIAL HYPERTENSION (1978) (5)
Pressor responsiveness in essential hypertension and the effects of treatment with an alpha blocker, calcium antagonist or ACE inhibitor. (1989) (5)
Nifedipine--studies on its mechanism of action and interaction with other circulatory control mechanisms in man. (1983) (4)
Circulatory effects of intravenous tyramine and noradrenalin in Parkinsonism. (1972) (4)
The recovery of alpha-adrenoceptor function and binding sites after phenoxybenzamine. An index of receptor turnover? (1984) (4)
Inhibitors of the renin-angiotensin system. Clinical pharmacology studies on kinetics, dynamics and concentration-effect relationships. (1993) (4)
The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosin (2004) (4)
Vascular Reactivity, Adrenergic Mechanisms, and Arteriolar Resistance in Hypertension (1988) (4)
Atenolol in the Management of Hypertension during Pregnancy (1983) (4)
Studies on the metabolic fate of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in man [proceedings]. (1977) (4)
Central Cardiovascular Effects of Rilmenidine and Neuropeptide Y in the Conscious Spontaneously Hypertensive Rat: Haemodynamic and Biochemical Evidence for a Negative Interaction (1992) (4)
THE EFFECTS OF INTRAVENOUS 6-HYDROXYDOPAMINE ON PERIPHERAL α-ADRENORECEPTORS (1982) (4)
α1-Adrenoceptor desensitisation (1988) (4)
The effects of sexual maturation on alpha-adrenoceptors in female rabbits. (1985) (4)
Brain catecholamines and catecholamine-synthesizing enzymes in renovascular hypertension in the rat. (1978) (4)
Plasma Noradrenaline in Pregnancy Associated Hypertension (1983) (4)
Fall and rise of polypharmacy? (2007) (4)
Haemodynamic and hormonal responses to losartan (DuP753/MK954) infusion during cardiac catheterization in conscious salt-deplete dogs. (1993) (4)
CONJUGATES OF 3-METHOXY-4-HYDROXYPHENYLETHYLENE GLYCOL IN MAN (1979) (4)
Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients (2004) (4)
Dopaminergic pathways and their pathophysiological significance. (1977) (4)
Nifedipine does not influence adrenaline induced hypokalaemia in man. (1983) (4)
Validation of blood pressure measuring systems. (1993) (4)
Oat cell carcinoma in the pancreas: an unusual cause of Cushing's syndrome. (1992) (4)
A clinical pharmacological study of nifedipine and lisinopril alone and in combination. (1987) (4)
Plasma Noradrenaline, Physical Activity and Systolic Blood Pressure in Hypertension (1978) (4)
Effects in Normotensive Subjects of Perindopril, an Angiotensin Converting Enzyme Inhibitor (1985) (4)
Relationship of plasma concentrations of levodopa to clinical response in Parkinsonsim. (1971) (4)
Plasma Noradrenaline as an Index of Sympathetic Activity (1980) (4)
24 Vascular pressor responses in treated and untreated essential hypertension (1988) (4)
Pharmacokinetics of guanfacine in the rabbit (1983) (4)
Pharmacodynamic studies on mianserin and its interaction with clonidine (2004) (4)
54 Haemodynamic and renal response to losartan during salt depletion or salt repletion (1993) (4)
Perindopril, a new angiotensin converting enzyme inhibitor--clinical pharmacological studies in healthy subjects. (1987) (4)
Modelling the pharmacokinetics and pharmacodynamics of trimazosin. (1986) (4)
Is end stage renal disease a common outcome among patients attending a hypertension clinic (2008) (3)
Do ace inhibitors reduce mortality in hypertensive patients (1998) (3)
Antihypertensive Drugs in the Elderly—the Evidence of Benefit (2004) (3)
The contribution of ambulatory blood pressure measurement to the evaluation of new antihypertensive drugs. (1991) (3)
Proceedings: Mechanism of the early pressor effect of centrally administered propranolol in the conscious rabbit. (1974) (3)
The effect of aging on alpha-adrenoceptors and their responses in rabbits. (1985) (3)
Plasma-catecholamines in phaeochromocytoma. (1976) (3)
Rapid and reversible desensitisation of vascular and platelet alpha2 adrenoceptors (1987) (3)
The effects of lead on catecholamine metabolism in rat brain regions (1981) (3)
THE EFFECTS OF AGE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CARDIOVASCULAR DRUGS: APPLICATION OF CONCENTRATION–EFFECT MODELING. 2. ACEBUTOLOL (1995) (3)
Dopamine supersensitivity in the hypothalamus? (1975) (3)
BP: a microcomputer program for use in a hypertension clinic. (1982) (3)
A Computer-Based Shared-Care Scheme for Hypertension in Glasgow: Feasibility and Acceptability (1990) (3)
Site of action of methyldopa in lowering the blood pressure in man. (1978) (3)
INTRACISTERNAL 6-HYDROXYDOPAMINE (6-OHDA) AND 5,6 DIHYDROXYTRYPTAMINE (5,6-DHT) IN EXPERIMENTAL HYPERTENSION (1974) (3)
An analysis of the pressor responses to putative alpha 1 and alpha 2-adrenoreceptor agonists given intravenously to conscious rabbits. (1984) (3)
2715 – COMPARISON OF CARDIOVASCULAR AND OTHER EFFECTS OF CLONIDINE AND BS 100-141 (1978) (3)
The effect of diuretic therapy on adrenaline-induced hypokalaemia and hypomagnesaemia (2004) (3)
Indirect assessment of tissue angiotensin II converting enzyme inhibition in vivo in man. (1988) (3)
The effects of lead on the renin-angiotensin system. (1985) (3)
Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects. (1991) (3)
Drug treatment: present and future. (1994) (3)
Clonidine and Imidazolines as Antihypertensive Agents (1982) (3)
Pharmacodynamic Studies with a Specific α2‐Adrenoceptor Agonist (BHT‐933) in Man (1982) (3)
Blood pressure responses to low-dose oral ester or intravenous diacid angiotensin converting enzyme inhibitors. (1991) (3)
Dichlorotetrafluoroacetone as a derivatisation reagent in the analysis of mandelic acids in human urine. (1990) (3)
An evaluation of the alpha-adrenoceptor antagonism produced by SK&F 86466 in healthy normotensive males. (1990) (3)
Optimal features of a new β-blocker (1988) (3)
Session I. Nervous Anatomy and Physiology of Cardiovascular Control and Orthostatic Regulation (1976) (3)
Regimen for the control of blood pressure and symptoms during clonidine withdrawal. (1985) (3)
The effects of omeprazole on gastric secretion in man (1983) (3)
Captopril and opiate antagonism in essential hypertension. (1986) (3)
A comparison of alpha 2-adrenoceptor regulation in brain and platelets. (1985) (3)
A032: Outcome differences between ACE inhibitor and calcium channel blocker treated hypertensives (2000) (3)
CAPTOPRIL AND THE MAINTENANCE OF BLOOD PRESSURE AFTER SINOAORTIC DENERVATION IN THE RABBIT (1981) (2)
The place of alpha blockers in the treatment of hypertension. (1993) (2)
Drug treatment--antihypertensive drugs--the present role of beta blockers and alpha blockers. (1999) (2)
Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects. (1991) (2)
Applications of deuterium labelling in pharmacokinetic and concentration-effect studies of clonidine (1978) (2)
ACE inhibitors: future perspectives. (1993) (2)
Effects of Ranitidine and Cimetidine on Plasma Lipoproteins in Healthy Subjects (1986) (2)
Effects of ketanserin on peripheral vascular pressor mechanisms in essential hypertension. (1988) (2)
Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin. (1988) (2)
Estrogen effects on nitric oxide release. (1997) (2)
Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade (1979) (2)
Cardiovascular reflex activity in Parkinsonism. (1971) (2)
Alpha-blockers and converting enzyme inhibitors. (1983) (2)
RISK‐BENEFIT OF SPECIFIC ANTIHYPERTENSIVE REGIMENS: RELEVANCE OF METABOLIC AND HAEMODYNAMIC EFFECTS OF α1‐BLOCKERS (1988) (2)
Plasma catecholamines and modes of delivery: the relation between catecholamine levels and in-vitro platelet aggregation and adrenoreceptor radioligand binding characteristics. (1985) (2)
Session IV. Therapy of Orthostatic Disturbances (1976) (2)
Selective alpha 2-adrenoceptor blockade does not enhance glucose-evoked insulin release. (1990) (2)
Vascular Pressor Responses in Treated and Untreated Essential Hypertension (1988) (2)
Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives. (1984) (2)
Metabolic consequences of salbutamol poisoning reversed by propranolol. (1982) (2)
Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension (1980) (2)
THE EFFECTS OF AGE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CARDIOVASCULAR DRUGS: APPLICATION OF CONCENTRATION–EFFECT MODELING. 1. TOLMESOXIDE (1995) (2)
Changes in α-Adrenoceptors During Long‐Term Treatment of Rabbits with Prazosin (1981) (2)
Compliance studies in ELSA. European Lacidipine Study of Atherosclerosis. (1996) (2)
Idazoxan and brain alpha 2-adrenoceptors in the rabbit. (1988) (2)
The effects of intravenous 6-hydroxydopamine on peripheral alpha-adrenoreceptors. (1982) (2)
Proceedings: Regional brain concentration of propranolol and its hypotensive effect of the conscious rabbit. (1974) (2)
The role of clinical pharmacology in the development and assessment of drugs for cerebrovascular disease and stroke. (1993) (2)
Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly. (1988) (2)
1399 – INTERINDIVIDUAL VARIATION IN NORADRENALINE KINETICS (1978) (2)
ADRENALINE CAUSES HYPOKALAEMIA IN MAN BY β2 ADRENOCEPTOR STIMULATON (1984) (2)
The role of the adrenergic system in hypertension after renal transplantation. (1981) (2)
Bucindolol in essential hypertension. (1985) (2)
Studies on central noradrenergic pathways in the control of body temperature (1974) (2)
The cardiovascular effects of clonidine in rabbits after cervical spinal cord transection [proceedings]. (1976) (2)
Bradykinin : a contribution to blood pressure reduction with ACE inhibition in man? (2000) (2)
Acute and Long-Term Actions of Prazosin in the Rabbit: Experimental Observations of the First Dose Effect (1981) (1)
The involvement of catecholamines in the central connexions of arterial baroreceptor reflexes in the rat [proceedings]. (1979) (1)
Journal of Hypertension 1988???1994 (1994) (1)
Desmethylimipramine and the hypotensive action of clonidine in the rabbit. (1973) (1)
9 Mechanisms Influencing the Haemodynamic Effects of Captopril in Man (1983) (1)
Comparison of the actions of central and peripheral administration of clonidine and BS 100-141 in the rabbit [proceedings]. (1978) (1)
Professional prospects in clinical pharmacology. The British experience. (1996) (1)
Adrenaline Induced Hypokalaemia is Increased by Treatment with Thiazide Diuretics (1983) (1)
Regulation of beta 1- and beta 2-adrenoceptors following chronic treatment with beta-adrenoceptor antagonists. (1989) (1)
Non-adrenergic binding of [3H]idazoxan and [3H]cionidine to rabbit forebrain and kidney membranes (1990) (1)
Plasma Noradrenaline Concentrations at Different Vascular Sites at Rest and during Isometric and Dynamic Exercise (1979) (1)
Actions of levodopa on the blood pressure of conscious rabbits (1973) (1)
Factors determining the response to angiotensin-converting enzyme inhibitors in hypertension. (1990) (1)
Adrenoceptors and postreceptor mechanisms in hypertension. (1988) (1)
Streptokinase for the Treatment of Acute Cerebral Infarction: A Placebo Controlled Pilot Study (1994) (1)
Clinical Evaluation of the Vasodilator MDL-899 in Patients with Essential Hypertension (1985) (1)
New antihypertensive drugs and new approaches to hypertension (1992) (1)
Double-blind, placebo controlled, cross-over comparison of the sedative and haemodynamic effect of single doses of clonidine and nitrazepam [proceedings]. (1979) (1)
Effects ofsingle andrepeated doses ofomeprazole on gastric acid andpepsin secretion inman (1984) (1)
29 – BIOCHEMICAL EVIDENCE FOR A NEUROTRANSMITTER ROLE FOR EPINEPHRINE IN BRAIN STEM AND SPINAL CORD (1977) (1)
Differences infirst doseresponse toangiotensin converting enzymeinhibition incongestive heart failure: aplacebo controlled study (1991) (1)
The acute and chronic effects of perindopril on renal sodium and water handling in patients with compendated hepatic cirrhosis (1992) (1)
Central action of drugs in blood pressure regulation : proceedings of an International Symposium on Central Actions of Drugs in the Regulation of Blood Pressure, under the auspices of the British Pharmacological Society (1975) (1)
Desensitization of vascular and platelet alpha 2-adrenoceptors in rabbits with perinephritis hypertension. (1988) (1)
Beta Blockade following Once Daily Dosing? A Comparison of Atenolol and Betaxolol (1986) (1)
The effect of calcium channel blockers on alpha 1- and alpha 2-adrenoceptor-mediated vascular responsiveness in man. (1985) (1)
21 Haemodynamic and neurohormonal responses to infusion of DUP753 in the conscious salt-deplete beagle (1991) (1)
CARDIOVASCULAR REACTIONS TO BROMOCRIPTINE (1979) (1)
Cardiovascular effects of Neuropeptide Y in the Caudal Ventrolateral Medulla (1988) (1)
1517 – MECHANISM OF THE PREVENTION OF DOCA SALINE HYPERTENSION BY CENTRAL 6–HYDR0XYD0PAMINE (1977) (1)
Treatment of high blood pressure--the effect on coronary morbidity and mortality. (1989) (1)
Binding studies of platelet a2- and lymphocyte ,32-adrenoceptors in patients with cirrhosis (2006) (1)
The Role of the Central Nervous System and the Renin Angiotensin System in Renovascular Hypertension in the Rat (1977) (1)
Optimal features of a new beta-blocker. (1988) (1)
Compliance studies in ELSA (1996) (1)
“Third drug” trial (1984) (1)
DO ace inhibitors protect against cancer (1998) (1)
Effect of baroreceptor deafferentation on central catecholamines in the rat. (1979) (1)
Evidence for a vagosympathetic bronchodilator reflex initiated by prostaglandin F2alpha [proceedings]. (1978) (1)
Adverse event with first-dose perindopril in congestive heart failure (1997) (1)
Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man. (1991) (1)
Repeated direct measurement of arterial pressure in conscious rabbits. (1973) (1)
The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man (1979) (1)
Volumeexpansion andvasodilators inthetreatment ofidiopathic postural hypotension (1980) (1)
5.3 Nitric oxide and superoxide balance in a model of genetic hypertension (1997) (1)
Changes in rabbit platelet alpha and beta adrenoceptor number and platelet aggregation. (1986) (1)
Plasma Noradrenaline and Selective Venous Sampling in the Diagnosis of Phaeochromocytoma (1977) (1)
alpha-Adrenoceptor regulation in vivo and in vitro in the rabbit. (1985) (1)
Hypertension in Theory and Practice (1994) (1)
Clinical pharmacological evaluation of calcium antagonists and other drugs modifying myogenic tone in essential hypertension. (1989) (1)
Effects of nicardipine on the metabolic responses to food and exercise. (1992) (1)
Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
Basal platelet intracellular free calcium concentrations in untreated hypertensive patients and normotensive controls. (1989) (0)
The haemodynamic effects of labetalol under conditions of increased levels of circulating catecholamines. (1983) (0)
A031: ACE inhibitors and outcome in treated hypertensive patients (2000) (0)
alpha-Adrenoceptors and hypertension. (1982) (0)
Emerging Clinical Applications of Ambulatory Blood Pressure Recording (1993) (0)
Importance of central catecholaminergic neurones in renal hypertension in rabbits. (1972) (0)
Decarboxylase Inhibitors and the Actions of α-Methyldopa in Man (1976) (0)
Plasma catecholamines and the acute effects of oral L-dopa in Parkinsonian patients [proceedings]. (1979) (0)
Strategies for management of hypertension — traditional approaches and new opportunities (1998) (0)
Action of levodopa on the blood pressure of conscious rabbits. (1973) (0)
Treatment oftheon-off syndrome inParkinsonism withlowdosebromocriptine incombination with levodopa (2011) (0)
Responses to Alpha???Adrenoceptor Agonist Infusions in Rabbits with Perinephritis Hypertension (1985) (0)
Changes in baroreflexes induced by L-dopa. (1972) (0)
The two dimensions of hypertension : metabolic and hemodynamic aspects and their role in pathophysiology and progression of the disease : proceedings of a satellite symposium held during the 6th European Meeting on Hypertension, June 4, 1993, Milan, Italy (1994) (0)
Imidazoline receptors in a comprehensive approach to hypertension : proceedings of an International Symposium held in Association with the Joint XIIth World Congress of Cardiology and XVIth Congress of the European Society of Cardiology, September 10, 1994 (1995) (0)
Hypertension in acute stroke (2008) (0)
Drug treatment of hypertension. (1993) (0)
Expert Answers to Three Key Questions What are the mechanisms of stroke ? - (2005) (0)
Cardiovascular Responses and Autonomic Nervous Function in Chronic Renal Failure Patients before and after Haemodialysis (1980) (0)
The Effects of Lacidipine on Insulin Sensitivity (1993) (0)
α-Adrenoceptor agonists and antagonists in the treatment of hypertension (1984) (0)
MATTERS ARISING (1994) (0)
Serum uric acid and stroke in hypertension: Influence of gender (2007) (0)
Medical Pharmacology: Principles and Concepts (1985) (0)
Calcium antagonists and their future clinical potential (1986) (0)
Oxygen 15 Inhalation Technique in the Study of Regional Cerebral Metabolism-to-Blood Flow Relationship in Man (1979) (0)
2373 – SOURCES OF FREE DOPAMINE (1978) (0)
12 Agonist-specific alterations in signal transduction in models of hypertension (1991) (0)
THE USE OF CALCIUM ANTAGONISTS IN HYPERTENSIVE PATIENTS WITH CONCOMITANT DISEASE : FOCUS ON NICARDIPINE, NICE, FRANCE, SEPTEMBER 13, 1989 (1990) (0)
Measurement of capillary cholesterol in hyperlipidemia. (1991) (0)
The influence of the novel alpha 2 adrenoceptor antagonist l 659066 on plasma insulin and glucose levels in healthy males (1989) (0)
Peripheral alpha 1- and alpha 2-adrenoreceptor mechanisms in blood pressure control. (1983) (0)
Central and Peripheral Alpha-Adrenoreceptors and the Actions of Clonidine and Methyldopa (1981) (0)
Ultraviolet Radiation and Vitamin D Synthesis in man (1981) (0)
Wednesday, May 19, Broadway Ballroom North, 10:00 AM to 12:30 PM: “I1, imidazoline receptors: Clinical relevance in hypertensive patients” (1999) (0)
Comprar Lecture Notes: Clinical Pharmacology and Therapeutics | Stephen Holland | 9781405135191 | Wiley (2009) (0)
Platelet cytosolic free calcium before and after antihypertensive treatment in perinephritis hypertension of the rabbit. (1989) (0)
Changes in tyrosine hydroxylase and phenylethanolamine N-methyl transferase activity in individual brain nuclei during the development of renovascular hypertension in the rat [proceedings]. (1978) (0)
Differences ininositol phosphate production inbloodvessels of normotensive andspontaneously hypertensive rats (1991) (0)
Skeletal muscle beta 2-adrenoreceptors and the effect of adrenergic drugs on plasma potassium in perinephritis hypertension in rabbits. (1989) (0)
84 Low-density lipoproteins, intracellular signalling in endothelial cells and the development of atherosclerosis (1993) (0)
2022 – NORADRENALINE AND ADRENALINE IN BRAIN STEM AND HYPOTHALAMIC NUCLEI IN EXPERIMENTAL RENOVASCULAR HYPERTENSION (1978) (0)
Regional impairment ofcerebral oxidative metabolism inParkinson's disease (1979) (0)
16 Altered Responsiveness of Arteries Taken from Rabbits with Perinephritis Hypertension (1983) (0)
The concentration effect relationships of clonidine in normotensive and hypertensive subjects (1976) (0)
Thepharmacokinetics ofdoxazosin inelderly normotensives (1986) (0)
The cardiovascular and endocrine effects of cilazapril, a new angiotensin-converting enzyme inhibitor, in man. (1990) (0)
A Study of Plasma Noradrenaline in the Population and its Contribution to the Long-Term Determination of Blood Pressure (1979) (0)
VALIDITY AND RELIABLITY OF 3 SELECTED BIA INSTRUMENTS IN PREDICTING BODY COMPOSITION OF PRE-MENOPAUSAL WOMEN (2001) (0)
Peripheral blood cell adrenoceptors as a model for receptors in the cardiovascular system (1986) (0)
Central effects of endothelin-1 on cerebral blood flow in the rat (1990) (0)
Wednesday, May 16, 4:00 PM to 6:00 PM Sympathetic Nervous System, I1 Imidazoline Receptors, Hypertension and Metabolic Disorders*: Update on rilmenidine – clinical benefits (2001) (0)
Session II. Physiopathology and Clinical Aspects of Cardiovascular Dysregulation, Especially Orthostatic (1976) (0)
CENTRAL CATECHOLAMINES AND RENOVASCULAR HYPERTENSION IN THE RAT (1979) (0)
Responsiveness to Calcium Antagonists in Essential Hypertension: Pharmacokinetic and Neurohumoral Aspects (1989) (0)
137 Lateral diffusion and fatty acid content in vascular smooth muscle cell membranes from stroke-prone spontaneously hypertensive rats (1993) (0)
Blood pressure and renin angiotensin system responses to initiation of treatment with captopril or losartan in heart failure. (1999) (0)
Endothelium Superoxide Anion Production Is Increased in a Model of Genetic Hypertension : Role of (1999) (0)
Clinical pharmacological studies with the vasodilator endralazine in patients with renal impairment (2004) (0)
17 Preliminary Experience with a Hospital Blood Pressure Follow-up Clinic Involving Nurse Practitioner Assessment and Microprocessor Based Data Retrieval (1984) (0)
Round table 1 : do transgenic techniques help us to understand hypertension ? (1993) (0)
42. Dose responses to cholesterol reduction with simvastatin and the effect on blood pressure control in treated hypertensive patients (1991) (0)
Cardiovascular dysfunction in ???white coat??? hypertension (1995) (0)
Pharmacokinetics of perindopril: therapeutic consequences. (1989) (0)
Central Nervous System Pharmacology: a Self-Instruction Text (1979) (0)
Metabolic andhaemodynamic effects ofincreased circulating adrenaline inman Effect oflabetalol, analpha andbeta blocker (1983) (0)
Effect of Propranolol on Plasma Norepinephrine during Sodium Nitroprusside-Induced Hypotension (1981) (0)
Clinical pharmacology and the management of cardiovascular diseases. (2003) (0)
Perindopril (Coversyl)--a new ACE inhibitor. Perindopril--a review of its pharmacokinetics and clinical pharmacology. (1991) (0)
Transpulmonary pharmacokinetics ofanACE inhibitor (perindoprilat) inman (1991) (0)
Kinetic‐dynamic relationships and antihypertensive mechanisms of ketanserin in essential hypertension (1988) (0)
RELATIONSHIPS DURING PREGNANCY (2006) (0)
Adimolol, a long acting beta-adrenoceptor blocker in man. (1987) (0)
A PHARMACODYNAMIC AND PHARMACOKINETIC ASSESS- MENT OFA NEW a-ADRENOCEPTORANTAGONIST,DOXAZOSIN (UK33274) INNORMOTENSIVE SUBJECTS (1982) (0)
Pharmacodynamic, pharmacokinetic and clinical profile of the first orally active angiotensin II receptor antagonist. (1995) (0)
P-485: High pulse pressure does not predict cardiovascular mortality in a general population of hypertensives (2003) (0)
Session III. Clinical Aspects of Orthostatic Dysregulation (1976) (0)
The Influence of Age on Noradrenaline Release and Clearance in Man (1980) (0)
The role of angiotensin II and nitric oxide in genetic hypertension: comparison with L-NAME hypertension (1996) (0)
MEASUREMENT OF CAPILLARY CHOLESTEROL LEVEL IN HYPERLIPIDAEMIA (1991) (0)
Nebivolol: The Role of Nitric Oxide in Hypertension Concluding Remarks (2001) (0)
First‐Choice Antihypertensive Drug Use in the Glasgow Blood Pressure Clinic (1990) (0)
ACE-INHIBITORS IN HEART FAILURE : ARE THERE DIFFERENT THERAPEUTIC RESPONSES ? (1997) (0)
The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide in essential hypertensives (2004) (0)
Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. (1998) (0)
Effects ofACE inhibitors on oxidation ofhumanlowdensity lipoprotein (1994) (0)
Studies on clonidine and guanfacine withdrawal after short term treatment in the rat. (1982) (0)
Effects ofnicardipine onaldosterone release andpressor mechanisms (1985) (0)
Clinical significance of receptor regulation in cardiovascular and respiratory diseases. Satellite symposium to the IV World Conference on Clinical Pharmacology and Therapeutics. Essen, FRG, July 28-30, 1989. Proceedings. (1990) (0)
Clinical Pharmacology of Psychotherapeutic Drugs (1979) (0)
Desensitisation of Platelet Alpha2 Adrenoceptors Following Short Term Adrenoceptor Agonist Infusions in Man (1984) (0)
The Pharmacokinetics and Pharmacodynamics of Verapamil in Elderly Hypertensives (1988) (0)
The effect of gender on basal nitric oxide release in a model of genetic hypertension (1995) (0)
The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha1-adrenoceptor responsiveness of trimazosin in man (2004) (0)
ESTROGEN EFFECTS ON NITRIC OXIDE RELEASE. AUTHORS' REPLY (1997) (0)
Concentration Effect Analysis of the Prazosin Derivatives, Trimazosin and Doxazosin (1982) (0)
66. Are clonidine, rilmenidine and related centrally acting antihypertensive drugs α2-adrenoceptor agonists? (1991) (0)
Fibrinogen Levels in Carotid Atherosclerosis and Cerebral Embolism (1995) (0)
Drug therapy in hypertension: risks and benefits. (1986) (0)
The effects of chronic beta adrenergic blockade on the relationship between plasma noradrenaline and systolic blood pressure in hypertensive man [proceedings]. (1978) (0)
Managing hypertension. (1992) (0)
18 Shared-care for hypertension in Glasgow (1991) (0)
2 Angiotensin II Stimulates Polyphosphoinositol Hydrolysis in Cultured Endothelial Cells from Rat Aorta: Relevance to Vascular Reactivity and Hypertension?: J.L. Bethesda (1987) (0)
Cardiovascular effects of alpha-adrenoceptor antagonists in the conscious rabbit [proceedings]. (1980) (0)
Alpha 1-adrenoceptor desensitisation. (1988) (0)
Y chromosome locus and hypertension in the stroke prone spontaneously hypertensive rat (1995) (0)
The role of aand fB-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat 1 (2006) (0)
Pretreatment with aspirin does not influence the pressor response to α2‐adrenoceptor agonists in conscious rabbits (1984) (0)
Cardiovascular outcomes after first-ever treatment of hypertension with angiotensin converting enzyme inhibitors or calcium channel-blockers in primary care (2003) (0)
β-Adrenoceptor-linked Na/K ATPase (1983) (0)
Regulation of beta-adrenoceptors by catecholamines in the rabbit skeletal muscle. (1988) (0)
Noradrenaline and endothelin-stimulated inositol phosphate formation in arterial smooth muscle from rabbits with perinephritis hypertension. (1991) (0)
5. Evidence for alterations in the calcium regulatory system in arterial smooth muscle isolated from rabbits with perinephritis hypertension (1988) (0)
The role of central and peripheral mechanisms in the maintenance of experimental hypertension in the rabbit. (1973) (0)

This paper list is powered by the following services:

Other Resources About John Reid

What Schools Are Affiliated With John Reid ?

John Reid is affiliated with the following schools:

John Reid 's Academic­Influence.com Rankings